1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6CDADC7D4A5BABDF500258A8C002FA2A6
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/insights/adapting-strategic-operations-next-gen-competitive-intelligence-2023-outlook-future-trends?opendocument
18
19opendocument
203.238.82.77
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25Main






Adapting Strategic Operations for Next-Gen Competitive Intelligence: 2023 Outlook and Future Trends

CHAPEL HILL, N.C., Dec. 21, 2023/PRNewswire/ -- In the ever-evolving biopharma landscape, understanding the trends shaping Competitive Intelligence (CI) is paramount. Navigating this dynamic environment demands a fortified CI strategy, meticulously aligned and armed with advanced capabilities

A recent study conducted by Best Practices, LLC reveals that major firms focus their training on CI policy education, presentation skills, and online tools

CI Training Scope:

  • CI guidelines developed internally - 60% at large companies, 32% at small companies
  • CI guidelines from industry professional associations - 33% at large companies, 53% at small companies
  • Presentation training - 53% at large companies, 47% at small companies
  • Online tools - 53% at large companies, 37% at small companies

“Strategic Operations in Competitive Intelligence: Current and Future Trends Transforming CI,” is a 43-page report that probes the intricacies of a successful biopharma CI function, highlighting significant shifts observed in recent years and key priorities which will shape the future of Competitive Intelligence.

Key topics addressed in this report:

  • Competitive Intelligence (CI) Evolution: Models, Reporting, Performance, and Structural Trends
  • Workforce Dynamics: Staffing, Activities, and Training Needs
  • AI Impact: Accelerated Integration in CI Organizations

The insights of this study were gained by engaging 22 Life Science organizations.

To learn more about this report, download a complimentary report excerpt at https://www.best-in-class.com/rw244.htm

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.